Survival of individuals with cerebral palsy receiving continuous intrathecal baclofen treatment: a matched-cohort study
Aim To determine whether intrathecal baclofen (ITB) changes mortality risk in persons with cerebral palsy (CP).Method Records were reviewed for all persons with CP who were managed with ITB for hypertonicity at a specialty hospital in Minnesota between May 1993 and August 2007. A comparison cohort was randomly selected from clients of the California Department of Developmental Services who were initially evaluated between 1987 and 1990 and were matched to those with ITB for age, sex, Gross Motor Function Classification System (GMFCS) level, presence or absence of epilepsy, and feeding-tube use. Survival probabilities were estimated using the Kaplan[ndash]Meier method, and differences were tested via log-rank.Results Three hundred and fifty-nine persons with CP (202 males, 157 females) rece…
Related posts:
- Continuous intrathecal baclofen for children with spasticity and/or dystonia: Goal attainment and complications associated with treatment
- The effect of gastrostomy tube feeding on body protein and bone mineralization in children with quadriplegic cerebral palsy
- The Effect of Frequency of Cerebral Palsy Treatment: A Matched-Pair Pilot Study
- Correlates of decline in gross motor capacity in adolescents with cerebral palsy in Gross Motor Function Classification System levels III to V: an exploratory study
- Continuous intrathecal baclofen therapy in children with cerebral palsy – when does improvement emerge?
Categories: Michigan Birth Injury News | | Permalink | Trackback |
Print This Post
|
Email This Post
